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Introduction

39
An increasing body of evidence implicates neuroinflammation in the aetiology of neurodegenerative 
51
Infectious meningitis caused by either M. tuberculosis or C. neoformans is characterised by the increase 52 of inflammatory and neural injury makers in the meninges [5] [6] [7] [8] . In both tuberculous and cryptococcal 53 meningitis (TBM and CM), up to half of survivors experience neurological sequelae with deficits that 54 may be similar to those in neurodegenerative diseases, such as impaired cognition and movement 55 disorder.
57
Here we report the results of a large-scale proteomic analysis comparing protein signatures in the CSF 58 from patients with or without infectious meningitis (TBM, CM, or viral meningoencephalitis, VM). We 59 identified a cluster of proteins that is functionally associated with neurodegenerative diseases, including 60 LRRK2, α-synuclein and tau. CSF abundance of these proteins was elevated in patients with TBM and 61 2 CM and positively correlated with inflammatory cytokines. Together, the data suggest that 62 neurodegeneration-associated proteins can be considered inflammatory markers themselves that 63 respond to infectious disease triggers.
65
Methods
67
Adults (age ≥18) with suspected meningitis who underwent lumbar puncture as part of their diagnostic 68 workup were recruited into a diagnostic study 9 
89
SOMAscan, an aptamer-based multiplexed proteomics assay, was used to measure the abundance 
94
SOMAscan data of all samples were hybridisation-normalised and adjusted for plate scaling factors
95
calculated from signals from the control probes. Statistical differences between patient groups of each
96
protein of interest were calculated using two-tailed Mann Whitney U test and p<0.05 was considered 97 significant. Correlation analysis was performed using the ggpubr package on R using Spearman's
98
Rank and p<0.05 was considered significant.
100
For Western Blotting, CSF proteins were precipitated with methanol (1:3 v/v). Proteins were detected 101 with the following antibodies: LRRK2 (clone N241A/34, NeuroMab; Davis CA, USA), α-synuclein
102
(clone MJFR1, Abcam, Cambridge UK), Tau (clone D1M9X) and β-actin-HRP (both from Cell
103
Signaling; Hitchin UK). Protein loading was assessed by Ponceau S staining.
105
Results
107
A total of 76 patients were enrolled into this study, including 20 with TBM (13 definite and 7 probable;
108
HIV-infected=17); 24 with CM (HIV-infected=24); seven with VM (HIV-infected=3) of whom two had
109
HSV meningitis; and 25 controls without meningitis (HIV-infected=6).
111
As previously reported, the proteomic analysis of CSF identified increased levels of inflammatory 112 cytokines, such as TNF-α, IL-1β and IFN-β in all meningitis samples (Fig 1A) . This was paralleled by 113 an increase in cerebral injury markers such as matrix metallopeptidase 9 (MMP-9), glial fibrillary acidic 114 protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) (Fig 1B) . TBM induced the highest 115 increase in both inflammatory cytokines and injury markers, and VM consistently showed only a mild 116 increase of these proteins. In addition to the inflammatory protein pattern, we observed an unexpected 117 increase in a group of proteins typically associated with neurodegenerative diseases, such as LRRK2,
118
tau and α-synuclein in patients with CM and TBM. Specifically, TBM showed 2-fold higher median levels 119 in tau and α-synuclein and a striking 10-fold elevation in LRRK2 levels, when compared to non-120 meningitis controls (Fig 2A) . We validated the proteomics findings by Western Blotting and confirmed 3 that LRRK2, α-synuclein and tau were significantly elevated in TBM, and to a lesser extent in CM, when 122 compared to CSF from control individuals (Fig 2B) .
124
Sub-analyses based on outcome were performed on CM and TBM where a subset of patients died,
125
thus were considered to have more severe infection at the time of sampling. While disease severity 126 impacted the CSF abundance of inflammatory cytokines (Figure 3A) , there were no difference in the 127 levels of these neurodegenerative disease-associated proteins (Figure 3B) , suggesting that the 128 aetiology may be a more important determinant. Sub-analysis on the impact of HIV-1 coinfection was 129 not performed on the three meningitis groups as the number of non-HIV-1 infected patients was too
130
small for statistical analysis.
132
Studies in PD showed that the CSF levels of neurodegeneration-related proteins significantly correlate
133
with inflammatory cytokines including TNF-α and IL-6 11,12
. Similarly, we found a significant correlation 134 between LRRK2 and the inflammatory cytokines TNF-α and IL-1β and the neural injury marker UCH-
135
L1 in TBM, CM and VM (Fig 4) 
170
Overall, this proteomic analysis suggest that certain proteins associated with neurodegeneration, and
171
PD in particular, can be considered as markers of inflammation, and that inflammatory triggers such as 172 infectious diseases can result in the shuttling of these neurotoxic proteins to the CNS.
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